SCALP PSORIASIS
Clinical trials for SCALP PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new SCALP PSORIASIS trials appear
Sign up with your email to follow new studies for SCALP PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study targets psoriasis treatment gap in skin of color patients
Disease control CompletedThis completed Phase 3 trial tested the drug guselkumab (Tremfya) in 211 people with skin of color who have moderate-to-severe plaque psoriasis or scalp psoriasis. Participants received either guselkumab or a placebo injection. The study measured how well the drug cleared skin le…
Matched conditions: SCALP PSORIASIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Shampoo shows promise for scalp psoriasis in small study
Disease control CompletedThis study tested Daxxin Psoriasis Shampoo in 41 adults with moderate scalp psoriasis. Participants used the shampoo 3 to 7 times a week for 6 weeks. The goal was to see if it reduced scalp redness, thickness, and scaling, and improved quality of life. Results showed most people …
Matched conditions: SCALP PSORIASIS
Phase: NA • Sponsor: Daxxin AB • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for psoriasis sufferers: drug targets Hard-to-Treat areas
Disease control CompletedThis study tested the drug risankizumab (Skyrizi) in 214 adults with moderate to severe genital or scalp psoriasis. Participants received either the drug or a placebo for 16 weeks, then all received the drug. The goal was to see if it could clear or nearly clear the skin in these…
Matched conditions: SCALP PSORIASIS
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC